I agree that this site is using cookies. You can find further informations here.
X
Kamachi, Kazuharu
61  results:
Search for persons X
?
1

KIR3DL1-HLA-Bw status in CML is associated with achievement..:

Ureshino, Hiroshi ; Ueda, Yasunori ; Fujisawa, Shin...
Blood Neoplasia.  1 (2024)  1 - p. 100001 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Second Treatment-Free Remission Attempt in Patients with Ch..:

Ureshino, Hiroshi ; Kamachi, Kazuharu ; Kimura, Shinya
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  4 - p. e138-e141 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Reprogramming of pyrimidine nucleotide metabolism supports ..:

Watanabe, Tatsuro ; Yamamoto, Yuta ; Kurahashi, Yuki...
Blood Advances.  8 (2024)  6 - p. 1345-1358 , 2024
Link: https://doi.org/10.1182/..
 
?
4

A Higher Neutrophil Count Is Associated with Favorable Achi..:

Ureshino, Hiroshi ; Takeda, Yusuke ; Kamachi, Kazuharu...
Clinics and Practice.  14 (2024)  4 - p. 1216-1224 , 2024
Link: https://doi.org/10.3390/..
 
?
5

DNA demethylating agents for chemoprevention of oncovirus-a..:

Yamamoto, Yuta ; Watanabe, Tatsuro ; Ureshino, Hiroshi...
Leukemia.  38 (2024)  7 - p. 1613-1616 , 2024
Link: https://doi.org/10.1038/..
 
?
6

Anaphylaxis and Severe Disseminated Intravascular Coagulati..:

Fukushima, Noriyasu ; Kamachi, Kazuharu ; Sato, Tomonori...
Internal Medicine.  63 (2024)  6 - p. 873-876 , 2024
Link: https://doi.org/10.2169/..
 
?
7

Dual targeting of aberrant DNA and histone methylation syne..:

Kurahashi, Yuki ; Watanabe, Tatsuro ; Yamamoto, Yuta...
Blood Advances.  7 (2023)  8 - p. 1545-1559 , 2023
Link: https://doi.org/10.1182/..
 
?
8

P476: AN ORAL COMBINATION THERAPY OF OR-2100 AND VENETOCLAX..:

Kamachi, Kazuharu ; Ureshino, Hiroshi ; Kawasoe, Kazunori...
HemaSphere.  7 (2023)  S3 - p. e73633b7 , 2023
Link: https://doi.org/10.1097/..
 
?
9

Diffuse Large B-cell Lymphoma Involving an Abundant Infiltr..:

Ishii, Keitaro ; Kamachi, Kazuharu ; Okamoto, Sho...
Internal Medicine.  62 (2023)  9 - p. 1335-1340 , 2023
Link: https://doi.org/10.2169/..
 
?
10

Type II Cryoglobulinemic Membranoproliferative Glomerulonep..:

Sugihara, Ayano ; Ureshino, Hiroshi ; Yamasaki, Masatora...
Internal Medicine.  62 (2023)  13 - p. 1983-1988 , 2023
Link: https://doi.org/10.2169/..
 
?
11

P1233: TUMOR PREVENTION USING DNA DEMETHYLATING AGENTS ON V..:

Yamamoto, Yuta ; Watanabe, Tatsuro ; Ureshino, Hiroshi...
HemaSphere.  7 (2023)  S3 - p. e50279db , 2023
Link: https://doi.org/10.1097/..
 
?
12

Combination of a New Oral Demethylating Agent, OR2100, and ..:

Kamachi, Kazuharu ; Ureshino, Hiroshi ; Watanabe, Tatsuro...
Cancer Research Communications.  3 (2023)  2 - p. 297-308 , 2023
Link: https://doi.org/10.1158/..
 
?
13

A Combination of Alectinib and DNA-Demethylating Agents Syn..:

Kawasoe, Kazunori ; Watanabe, Tatsuro ; Yoshida-Sakai, Nao...
Cancers.  15 (2023)  20 - p. 5089 , 2023
Link: https://doi.org/10.3390/..
 
?
14

P1236: REGULATION OF DNA AND HISTONE METHYLATION THROUGH ME..:

Watanabe, Tatsuro ; Kitamura, Sho ; Kai, Keita...
HemaSphere.  7 (2023)  S3 - p. e325001a , 2023
Link: https://doi.org/10.1097/..
 
?
15

P654: ALLELIC POLYMORPHISMS OF KIRS AND HLAS PREDICT FAVORA..:

Ureshino, Hiroshi ; Ueda, Yasunori ; Fujisawa, Shin...
HemaSphere.  7 (2023)  S3 - p. e9072115 , 2023
Link: https://doi.org/10.1097/..
 
1-15